首页 › 基金 › Burkehill Global Management, LP › BBIO

Burkehill Global Management, LP 对 BBIO 的持仓历史

BRIDGEBIO PHARMA INC · 医疗保健

Burkehill Global Management, LP 在 Q3 2026 的 13F 申报中披露持有 BBIO(BRIDGEBIO PHARMA INC)100,000 股,市值约 US$6.6M,约占其申报组合的 0.29%,在其申报持仓中市值排名第 44 位。 Burkehill Global Management, LP 最近 6 个申报季度中有 3 个季度披露了 BBIO 持仓,最早可追溯至 Q2 2025。

最新持仓 (Q3 2026)100.00K 股
申报持仓市值$6.58M
组合权重0.29%
首次申报Q2 2025
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Burkehill Global Management, LP 对 BBIO 的持仓演变

Burkehill Global Management, LP 于 Q2 2025 首次披露 BBIO 持仓:275,000 股(约 US$11.9M)。 该持仓在 Q3 2025 达到峰值 275,000 股,市值约 US$14.3M。 在 3 次申报中,Burkehill Global Management, LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 100,000 股、市值约 US$6.6M。

逐季持仓明细

季度股数金额变化
Q2 2025 275.00K $11.87M 新进
Q3 2025 275.00K $14.28M 持有
Q3 2026 100.00K $6.58M 新进

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BBIO 与 13F 数据

BBIO(BRIDGEBIO PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 BBIO,申报仓位最大的包括:Jupiter Topco LLC (US$1.05B), 骏利亨德森集团 (US$957.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$937.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BBIO 的基金

查看 BBIO 的全部基金持有人 →

常见问题

How long has Burkehill Global Management, LP held BBIO?

Burkehill Global Management, LP has disclosed BBIO holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

What is Burkehill Global Management, LP's current position in BBIO?

As of Q3 2026, Burkehill Global Management, LP holds 100.00K shares of BBIO (BRIDGEBIO PHARMA INC), valued at $6.58M, representing 0.29% of its reported portfolio and ranking #44.

Has Burkehill Global Management, LP been buying or selling BBIO?

In the latest 13F filing (Q3 2026), Burkehill Global Management, LP newly opened its position in BBIO. The position peaked in Q3 2025 at 275.00K shares.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, 骏利亨德森集团, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.